61 related articles for article (PubMed ID: 19228523)
1. Hepatic Arterial Buffer Response in Liver Transplant Recipients: Implications and Treatment Options.
Spaggiari M; Martinino A; Ray CE; Bencini G; Petrochenkov E; Di Cocco P; Almario-Alvarez J; Tzvetanov I; Benedetti E
Semin Intervent Radiol; 2023 Feb; 40(1):106-112. PubMed ID: 37152797
[No Abstract] [Full Text] [Related]
2. Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study.
Tomiyama T; Harada N; Toshima T; Nakayama Y; Toshida K; Morinaga A; Kosai-Fujimoto Y; Tomino T; Kurihara T; Takeishi K; Nagao Y; Morita K; Itoh S; Yoshizumi T
Transpl Int; 2022; 35():10723. PubMed ID: 36568139
[TBL] [Abstract][Full Text] [Related]
3. Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation.
Ikegami T; Kim JM; Jung DH; Soejima Y; Kim DS; Joh JW; Lee SG; Yoshizumi T; Mori M
Korean J Transplant; 2019 Dec; 33(4):65-73. PubMed ID: 35769983
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation.
Elshawy M; Toshima T; Asayama Y; Kubo Y; Ikeda S; Ikegami T; Arakaki S; Yoshizumi T; Mori M
Surg Case Rep; 2020 Jul; 6(1):164. PubMed ID: 32642985
[TBL] [Abstract][Full Text] [Related]
5. Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy.
Yoshizumi T; Mori M
Surg Today; 2020 Jan; 50(1):21-29. PubMed ID: 31555908
[TBL] [Abstract][Full Text] [Related]
6. Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation.
Bang JB; Kim BW; Kim YB; Wang HJ; Lee HY; Sim J; Kim T; Lee KL; Hu XG; Mao W
World J Gastroenterol; 2016 Aug; 22(30):6925-35. PubMed ID: 27570428
[TBL] [Abstract][Full Text] [Related]
7. Strategies to treat interferon-induced graft dysfunction after living donor liver transplantation for hepatitis C.
Ikegami T; Wang H; Yoshizumi T; Toshima T; Aishima S; Fukuhara T; Furusyo N; Kotoh K; Shimoda S; Shirabe K; Maehara Y
Hepatol Int; 2014 Apr; 8(2):285-92. PubMed ID: 26202510
[TBL] [Abstract][Full Text] [Related]
8. Optimal changes in portal hemodynamics induced by splenectomy during living donor liver transplantation.
Wang H; Ikegami T; Harada N; Yoshizumi T; Soejima Y; Uchiyama H; Yamashita Y; Itoh S; Harimoto N; Kawanaka H; Shirabe K; Maehara Y
Surg Today; 2015 Aug; 45(8):979-85. PubMed ID: 25080864
[TBL] [Abstract][Full Text] [Related]
9. A high MELD score, combined with the presence of hepatitis C, is associated with a poor prognosis in living donor liver transplantation.
Ikegami T; Shirabe K; Yoshiya S; Yoshizumi T; Yamashita Y; Harimoto N; Toshima T; Uchiyama H; Soejima Y; Maehara Y
Surg Today; 2014 Feb; 44(2):233-40. PubMed ID: 23435837
[TBL] [Abstract][Full Text] [Related]
10. Antegrade en bloc distal pancreatectomy with plexus hanging maneuver.
Ikegami T; Maeda T; Oki E; Kayashima H; Ohgaki K; Sakaguchi Y; Shirabe K; Maehara Y
J Gastrointest Surg; 2011 Apr; 15(4):690-3. PubMed ID: 21061178
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension.
Zhan XL; Ji Y; Wang YD
World J Gastroenterol; 2014 May; 20(19):5794-800. PubMed ID: 24914339
[TBL] [Abstract][Full Text] [Related]
12. [Portal splenic congestion. Its significance for surgery of portal hypertension and for other epigastric surgical interventions].
Ebber G
Chirurg; 1973 Jul; 44(7):301-3. PubMed ID: 4737978
[No Abstract] [Full Text] [Related]
13. [Indications of splenectomy].
Körtge P
Internist (Berl); 1967 Oct; 8(10):357-71. PubMed ID: 4876267
[No Abstract] [Full Text] [Related]
14. Bloodless splenectomy during liver transplantation for terminal liver diseases with portal hypertension.
Ikegami T; Toshima T; Takeishi K; Soejima Y; Kawanaka H; Yoshizumi T; Taketomi A; Maehara Y
J Am Coll Surg; 2009 Feb; 208(2):e1-4. PubMed ID: 19228523
[No Abstract] [Full Text] [Related]
15. [Partial resection of the spleen and spleno-renal shunt in the treatment of portal hypertension with splenomegaly and hypersplenism].
Radević B; Jesić R; Sagić D; Perisić V; Nenezić D; Popov P; Ilijevski N; Dugalić V; Gajin P; Vucurević G; Radak Dj; Trebjesanin Z; Babić D; Kastratović D; Matić P
Acta Chir Iugosl; 2002; 49(3):93-8. PubMed ID: 12587456
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic splenectomy is a safe and effective procedure for patients with splenomegaly due to portal hypertension.
Hama T; Takifuji K; Uchiyama K; Tani M; Kawai M; Yamaue H
J Hepatobiliary Pancreat Surg; 2008; 15(3):304-9. PubMed ID: 18535769
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
